Cochlear | COH - UTANG

Keuangan

AUD 132.55

AUD 2.79B

AUD 275.7M

Biaya Penjualan

AUD 319.2M

AUD 1.37B

Kewajiban Lancar

AUD 558.9M

AUD 235.7M

Dividen - Hasil

1.17

AUD 261.1M

AUD 306.4M

5.5K

Eps Laba Per Saham

AUD 3.13

Modal Dan Cadangan

AUD 1.94B

Laba Kotor Pada Penjualan

AUD 856.8M

Beban Bunga Utang

AUD 6.3M

Pendapatan Bunga

AUD 7.4M

AUD 200M

Kapitalisasi Pasar

AUD 8.67B

Batas Pemasukan

AUD 161.5M

Biaya Operasional

AUD 914.9M

Laba Operasional

AUD 261.1M

Modal Saham Biasa

AUD 65.4M

Pe Harga Untuk Laba

43.67

Laba Sebelum Pajak

AUD 121.1M

Pendapatan Penjualan

AUD 1.18B

Beban Penjualan Dan Administrasi

AUD 449.4M

AUD 499.4M

Kreditur Perdagangan

AUD 281.3M

Debitur Perdagangan

AUD 568.4M

	UTANG	Perubahan		Tanggal
Ansell	USD 805.6M		51.6M	2025-06
Avita Medical	AUD 46.05M		1.46M	2025-12
Cochlear	AUD 235.7M		10.9M	2025-06
CSL	USD 11.96B		219M	2024-12
Healius	AUD 1.4B		199.1M	2024-12
Integral Diagnostics	AUD 357.8M		3.7M	2024-06
Mayne Pharma	AUD 38.82M		2.24M	2024-06
Mesoblast	USD 135.14M		6.99M	2025-12
Monash IVF	AUD 159.39M		24.02M	2024-12
Nanosonics	AUD 7.69M		1.49M	2025-06
Polynovo	AUD 15.38M		49K	2024-06
Ramsay Health Care	AUD 12.12B		864.4M	2025-06
Regis Healthcare	AUD 5.11M		807K	2025-06
ResMed	USD 843.17M		3.18M	2026-03
Sigma Healthcare	AUD 137.64M		1.01M	2024-07
Somnomed	AUD 23.51M		534.68K	2023-06
Sonic Healthcare	AUD 4.8B		282.9M	2024-12
Telix Pharmaceuticals	AUD 467.11M		48.85M	2025-12